Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 376, P. 972 - 984
Published: Nov. 6, 2024
Language: Английский
Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 376, P. 972 - 984
Published: Nov. 6, 2024
Language: Английский
Cells, Journal Year: 2025, Volume and Issue: 14(7), P. 542 - 542
Published: April 3, 2025
Asthma is a complex, multifactorial inflammatory disorder of the airways, characterized by recurrent symptoms and variable airflow obstruction. So far, two main asthma endotypes have been identified, type 2 (T2)-high or T2-low, based on underlying immunological mechanisms. Recently, extracellular vesicles (EVs), particularly exosomes, gained increasing attention due to their pivotal role in intercellular communication distal signaling modulation. In context pathobiology, an amount experimental evidence suggests that EVs secreted eosinophils, mast cells, dendritic T neutrophils, macrophages, epithelial cells contribute disease This review explores profiling molecular signatures T2-high T2-low asthma, offering novel perspectives mechanisms potential therapeutic targets.
Language: Английский
Citations
0Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 376, P. 972 - 984
Published: Nov. 6, 2024
Language: Английский
Citations
0